Study details
Enrolling now
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
Massachusetts General Hospital
NCT IDNCT06525623ClinicalTrials.gov data as of Apr 2026
Target enrollment
50
Study length
about 2 years
Ages
18+
Locations
1 site in MA
What this study is about
This trial is testing whether giving fluids to patients with acute kidney injury and cirrhosis, based on a specific guideline (VAGA), or standard IV albumin is safer and more effective. The goal is to determine the best way to manage fluid needs in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Recommendation: Standard of Care IV Albumin
- 2.Recommendation: No Further Resuscitation
- 3.Recommendation: Resuscitation with Colloid
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Incidence of treatment-emergent adverse events and serious adverse events
Body systems
Renal